Bank of Montreal’s Annovis Bio ANVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,500
Closed -$109K 3509
2024
Q3
$109K Buy
+13,500
New +$126K ﹤0.01% 3217
2021
Q4
Sell
-9,500
Closed -$318K 3484
2021
Q3
$318K Buy
+9,500
New +$546K ﹤0.01% 3104

Other funds holding ANVS

Bank of Montreal's ANVS Position: Q4 2024 in Review

Bank of Montreal sold out of Annovis Bio (ANVS) in Q4 2024, closing a stake of 13,500 shares — an estimated $109K sold.

Bank of Montreal first reported a position in ANVS in Q3 2021 and held it in 2 quarters. The position peaked at $318K in Q3 2021. 40 funds tracked by Wall St. Rank hold ANVS as of Q4 2024.

  • Bank of Montreal reported no remaining Annovis Bio position as of Q4 2024 after selling out during the quarter.
  • Bank of Montreal sold 13,500 Annovis Bio shares in Q4 2024, an estimated $109K.
  • Bank of Montreal first reported a position in Annovis Bio in Q3 2021 and held it in 2 quarters.
  • Bank of Montreal's Annovis Bio position peaked at $318K in Q3 2021.
  • 40 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2024.

Based on Bank of Montreal's 13F filing for Q4 2024, filed 13 Feb 2025.